Yvette Kasamon, M.D.

Yvette Kasamon, M.D., is a clinical team leader in the Division of Hematologic Malignancies II within the Office of Oncologic Diseases at the Food and Drug Administration (FDA).   Before joining the FDA in 2015, she completed an internal medicine residency at the Brigham and Women’s Hospital and a hematology-oncology fellowship at Johns Hopkins University, then joining its faculty as a clinical investigator with a focus on lymphoma.  Dr. Kasamon’s clinical and regulatory interests include Hodgkin lymphoma, non-Hodgkin lymphoma, and CLL.  She remains an Adjunct Associate Professor of Oncology at Johns Hopkins.